This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Fabiana Falugi: Innovator in Antigen Stability
Introduction
Fabiana Falugi is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of biotechnology, particularly in enhancing antigen stability through innovative methods.
Latest Patents
Falugi holds a patent titled "Elimination of disulphide bond formation of cysteine-containing antigens enhances antigen stability." This invention provides variant forms of cysteine-containing antigens with a point mutation that replaces, deletes, or modifies the cysteine residue. She has 1 patent to her name, showcasing her expertise in this specialized area.
Career Highlights
Fabiana is associated with GlaxoSmithKline Biologicals SA, where she applies her knowledge and skills to advance research in the field. Her work focuses on improving the stability of antigens, which is crucial for vaccine development and other therapeutic applications.
Collaborations
Throughout her career, Falugi has collaborated with notable colleagues, including Fabio Bagnoli and Guido Grandi. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Fabiana Falugi is a trailblazer in the field of antigen stability, with her innovative patent reflecting her commitment to advancing biotechnology. Her work continues to impact the industry positively, paving the way for future developments in vaccine and therapeutic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile